Can CAM therapies help reduce antibiotic resistance?

Alternative Medicine Review

Volumn 8, Issue 1, 2003, Pages 28-42

  MacKay, Douglas ^a  

^a Thorne Research Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ARABINOGALACTAN; ASCORBIC ACID; ASTRAGALUS MEMBRANACEUS EXTRACT; DECONGESTIVE AGENT; ECHINACEA EXTRACT; ERYTHROMYCIN; FISH OIL; GARLIC EXTRACT; HERBACEOUS AGENT; IBUPROFEN; MINERAL; MULTIVITAMIN; PARACETAMOL; STEROID; THYMUS EXTRACT; VARICELLA ZOSTER VACCINE;

ALTERNATIVE MEDICINE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG USE; ENVIRONMENTAL FACTOR; HEALTH CARE COST; HOMEOPATHY; HUMAN; HYDROTHERAPY; INFECTION; NUTRIENT; OTITIS MEDIA; OUTPATIENT CARE; PEDIATRICS; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED STATES; VACCINATION; VIRUS INFECTION;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; COMPLEMENTARY THERAPIES; DRUG RESISTANCE, BACTERIAL; HOMEOPATHY; HUMANS; HYDROTHERAPY; HYPERSENSITIVITY; MEDICINE, HERBAL; OTITIS MEDIA WITH EFFUSION; PHYTOTHERAPY; PRACTICE GUIDELINES; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 0037298135     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Centers for Disease Control and Prevention (CDC). 2001;www.cdc.gov
2. Kunin CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;151:388-398.
3. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997;337:491-492.
4. Pichichero ME, Reiner SA, Brook I, et al. Controversies in the medical management of persistent and recurrent otitis media. Recommendations of a clinical advisory committee. Ann Otol Rhinol Laryngol Suppl 2000;183:1-12.
5. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-219.
6. Bergus GR, Levy BT, Levy SM, et al. Antibiotic use during the first 200 days of life. Arch Fam Med 1996;5:523-526.
7. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective cohort study. J Infect Dis 1989;160:83-94.
8. Werk LN, Bauchner H. Practical considerations when treating children with antimicrobials in the outpatient setting. Drugs 1998;55:779-790.
9. Schwartz RH, Freij BJ, Ziai M, Sheridan MJ. Antimicrobial prescribing for acute purulent rhinitis in children: a survey of pediatricians and family practitioners. Pediatr Infect Dis J 1997;16:185-190.
10. Hueston WJ, Dickerson L. Antibiotic resistance and the need for the rational use of antibiotics. JMed Liban 2001;49:246-256.
11. File TM Jr., Hadley JA. Rational use of antibiotics to treat respiratory tract infections. Am J Manag Care 2002;8:713-727.
12. Steinberg I. Clinical choices of antibiotics: judging judicious use. Am J Manag Care 2000;6:S1178-S1188.
13. Hardy LM, Traisman HS. Antibiotics and chemotherapeutic agents in the treatment of uncomplicated respiratory infections in children: a controlled study. J Pediatr 1956;48:146-156.
14. Townsend EH Jr., Radebaugh JF. Prevention of complications of respiratory illness in pediatric practice: a double-blind study. N Engl J Med 1962;266:683-689.
15. Hoagland RJ, Deitz EN, Myers PW, et al. Aureomycin in the treatment of the common cold. N Engl J Med 1950;243:773-775.
16. Lexomboon U, Duangmani C, Kusalasai V, et al. Evaluation of orally administered antibiotics for the treatment of upper respiratory infections in Thai children. J Pediatr 1971;78:772-778.
17. Soyka LF, Robinson DS, Lachant N, Monaco J. The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics 1975;55:552-556.
18. Steinweg KK. Natural history and prognostic significance of purulent rhinitis. J Fam Pract 1983;17:61-64.
19. Bauchner H, Phillip B. Reducing inappropriate oral antibiotic use: a prescription for change. Pediatrics 1998;102:142-145.
20. Nollette KA. Antimicrobial resistance. J Am Acad Nurse Pract 2000;12:286-296.
21. American Academy of Pediatrics. 2002 Immunization Schedule. http://www.aap.org/family/parents/immunize.htm
22. Kleinman LC, Kosecoff J, Dubois RW, Brook RH. The medical appropriateness of tympanostomy tubes proposed for children younger than 16 years in the United States. JAMA 1994;271:1250-1255.
23. Spilseth P. Appropriateness of tympanostomy tubes. Fam Pract Res J 1992;12:43-52.
24. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992;11:278-286.
25. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotics use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1-7.
26. Klein JO. Management of otitis media with antimicrobial agents. Curr Clin Top Infect Dis 2000;20:174-188.
27. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburg-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997;99:318-333.
28. Klein JO, Bluestone CD. Management of otitis media in the era of managed care. Adv Pediatr Infect Dis 1996;12:351-368.
29. Otitis Media Guideline Panel. Otitis Media with Effusion in Young Children: Clinical Practice Guideline. Rockville, MD: Agency for Health Care Policy and Research; 1994.
30. Froom J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997;315:98-102.
31. van Buchem FL, Peeters MF, van 't Hof MA. Acute otitis media: a new treatment strategy. Br Med J (Clin Res Ed) 1985;290:1033-1037.
32. Appleman CLM, Bossen PC, Dunk JHM, et al. Guideline. Dutch College of Family Doctors. Acute Otitis Media. Utrecht: Dutch College of Family Doctors; 1990.
33. Marcy SM. General information and practitioner guidelines for otitis media. APUA Newsletter. 1999; http://www.tufts.edu/med/apua/Practitioners/AOMguidelines.html
34. Klein JO. Management of acute otitis media in an era of increasing antibiotic resistance. Int J Pediatr Otorhinolaryngol 1999;49:S15-S17.
35. Rosenfeld RM. Amusing parents while nature cures otitis media with effusion. Int J Pediatr Otorhinolaryngol 1998;43:189-192.
36. Rosenfeld RM. What to expect from medical treatment of otitis media. Pediatr Infect Dis J 1995;14:731-738.
37. Lehnert T. Acute otitis media in children. Role of antibiotic therapy. Can Fam Physician 1993;39:2157-2162.
38. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr 1994;124:355-367.
39. Melchart D, Walther E, Linde K, et al. Echinacea root extracts for the prevention of upper respiratory tract infections. Arch Fam Med 1998;7:541-545.
40. Barrett B, Vohmann M, Calarese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-635.
41. Mark JD, Grant KL, Barton LL. The use of dietary supplements in pediatrics: A study of Echinacea. Clin Pediatr 2001;40:265-269.
42. Hauer J, Anderer FA. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis. Cancer Immunol Immunother 1993;36:237-244.
43. D'Adamo P. Larch arabinogalactan. JNaturopath Med 1996;6:33-37.
44. Wagner H. Low molecular weight polysaccharides from composite plants containing arabinogalactan, arabinoglucan, and arabinoxylan. Bundesrepublik Deutsches Paentamt DE 3042491 7/15/82. [German Patent]
45. Kiremidjian-Schumacher L, Stotsky G. Selenium and immune responses. Environmental Res 1987;42:277-303.
46. Kiremidjian-Schumacher L, Roy M, Wishe HI, et al. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41:115-127.
47. Roy M, Kiremidjian-Schumacher L, Wishe HI, et al. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994;41:103-114.
48. Lindlay LA, Dolitsky JN, Shindledecker RD, Pippenger CE. Lemon-flavored cod liver oil and a multivitamin-mineral supplement for the secondary prevention of otitis media in young children: pilot research. Ann Otol Rhinol Laryngol 2002;111:642-652.
49. Fowler WP. Ein Fall von otitis media haemorrhagica. Allg Homoopath Z 1880;101:182-183. [Article in German]
50. Stager R. Otitis media purulenta chronica. Allg Homoopath Z 1899;138:105. [Article in German]
51. Friese KH, Kruse S, Lutke R, Moeller H. The homeopathic treatment of otitis media in children - comparison with conventional therapy. Int J Clin Pharmacol Ther 1997;35:296-301.
52. Harrison H, Fixsen A, Vickers A. A randomized comparison of homeopathic and standard care for the treatment of glue ear in children. Complement Ther Med 1999;7:132-135.
53. Jacobs J, Springer DA, Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis 2001;20:177-183.
54. Bernstein JM. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion. Otolaryngol Clin North Am 1992;25:197-211.
55. Bernstein JM. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion: a review. Otolaryngol Head Neck Surg 1993;109:611-620.
56. Bernstein JM. Recent advances in immunologic reactivity in otitis media with effusion. J Allergy Clin Immunol 1988;81:1004-1009.
57. Fernandez AA, McGovern JP. Secretory otitis media in allergic children and infants. South Med J 1965;50:581-589.
58. Ackerman M, Friedman R, Doyle W, et al. Studies of eustachian tube obstruction after provocative nasal challenge. J Allergy Clin Immunol 1983;77:155-159.
59. Doyle WJ, Friedman R, Fireman P. Eustachian tube obstruction after provocation nasal antigen challenge. Arch Otolaryngol 1984;110:508-511.
60. Friedman R, Doyle WJ, Cassellbrant ML, et al. Immunologically mediated eustachian tube obstruction: a double blind study. J Allergy Clin Immunol 1983;71:442-447.
61. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981;305:841-846.
62. Wilson WH. The role of allergy in otitis media with effusion. Arch Otolaryngol Head Neck Surg 1986;112:454-455.
63. Heiner DC. Respiratory diseases and food allergy. Ann Allergy 1984;53:657-664.
64. Hanson LA, Korotkova M, Haversen L, et al. Breast-feeding, a complex support system for the offspring. Pediatr Int 2002;44:347-352.
65. Aniansson G, Svensson H, Becker M, Ingvarsson L. Otitis media and feeding with breast milk of children with cleft palate. Scand J Plast Reconstr Surg Hand Surg 2002;36:9-15.
66. Rodrigo C. Prevention of acute otitis media. Clin Microbiol Infect 1997;3:S55-S58.
67. Baraibar R. Incidence and risk factors of acute otitis media in children. Clin Microbiol Infect 1997;3:S13-S22.
68. Wilson WH. Recurrent acute otitis media in infants - role of immune complexes acquired in utero. Laryngoscope 1983;93:418-421.
69. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate use for treatment of uncomplicated acute bronchitis: background. Ann Int Med 2001;134:521-529.
70. Snow V. Guidelines for antibiotic use from the American College of Physicians. APUA Newsletter 2001;19:1-3.
71. O'Brien KL, Dowell SF, Schwartz B, et al. Cough illness/bronchitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:178-181.
72. Stott NC, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J 1976;2:556-559.
73. King DE, Williams WC, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996;42:601-605.
74. Williamson HA Jr. A randomized, controlled trial of doxycycline in treatment of acute bronchitis. J Fam Pract 1984;19:481-486.
75. Verheij TJ, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994;44:400-404.
76. Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 1986;23:119-122.
77. Franks P, Gleiner JA. The treatment of acute bronchitis with trimethroprim and sulfamethoxazole. J Fam Pract 1984;19:185-190.
78. Dunlay J, Reinhardt R, Roi LD. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987;25:137-141.
79. Howie JG, Clark GA. Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice. Lancet 1970;2:1099-1102.
80. Scherl ER, Riegler SL, Cooper JK. Doxycycline in acute bronchitis: a randomized double-blind trial. J Ky Med Assoc 1987;85:539-541.
81. Orr PH, Scherer K, Macdonald A, Moffatt ME. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993;36:507-512.
82. Wald ER. Sinusitis in children. N Eng J Med 1992;326:319-323.
83. O'Brien KL, Dowell SF, Schwartz B, et al. Acute sinusitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:174-177.
84. Cambell LR. Pharyngitis, tonsillitis (group A streptococcal), and scarlet fever. In: Garfunkel LC, Kaczorowski J, Christy C, eds. Mosby's Pediatric Clinical Advisor. St. Louis, MO: Mosby, Inc; 2002:585-586.
85. Schwartz B, Marcy SM, Phillips WR, et al. Pharyngitis - principles of judicious use of antimicrobial agents. Pediatrics 1998;101:171-174.
86. Swartout HO. The New Modern Medical Counselor. Mountain View, CA: Pacific Press Publishing Association; 1951:341-403.
87. Shoseyov D, Bibi H, Shai P, et al. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998;101:602-605.
88. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189-1193.
89. Grossan M. Nasal irrigation. Laryngoscope 2001;111:1867-1868. [Letter]
90. The Burton Goldberg Group. Alternative Medicine: The Definitive Guide. Puyallup, WA: Future Medicine Publishing, Inc; 1994:604.
91. Yoshida Y, Wang MQ, Liu JN, Yamashita U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol 1997;19:359-370.
92. Chang HM, But PPh, eds. Pharmacology and Application of Chinese Materia Medica, vol 2. Singapore: World Scientific; 1987:1041-1046.
93. Hong YH. Oriental Materia Medica: A Concise Guide. Long Beach, CA: Oriental Healing Arts Institute; 1986.
94. Chu DT, Wong WL, Mavlight GM. Immunotherapy with Chinese medicinal herbs. J Clin Lab Immunol 1998;25:119-129.
95. Longo F, Lepore L, Agosti E, Panizon F. Evaluation of the effectiveness of thymomodulin in children with recurrent respiratory infections. Pediatr Med Chir 1988;10:603-607. [Article in Italian]
96. Galli L, de Martino M, Azzari C, et al. Preventive effect of thymomodulin in recurrent respiratory infections in children. Pediatr Med Chir 1990;12:229-232. [Article in Italian]
97. Bendich A. Vitamin C and immune responses. Food Technol 1987;41:112-114.
98. Banic S. Immunostimulation by vitamin C. IntJ Vitamin Nutr Res Suppl 1982;23:49-52.
99. Hemila H. Vitamin C supplementation and the common cold symptoms: factors affecting the magnitude of the benefit. Med Hypothesis 1999;52:171-178.
100. Carr AB, Einstein R, Lai LY, et al. Vitamin C and the common cold: using identical twins as controls. Med J Aust 1981;2:411-412.
101. Miller JZ, Nance WE, Norton JA, et al. Therapeutic effect of vitamin C. A co-twin control study. JAMA 1977;237:248-251.
102. Tanzer F, Ozalp I. Leucocyte ascorbic acid concentration and plasma ascorbic acid levels in children with various infections. Mater Med Pol 1993;25:5-8.
103. Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis 1999;3:756-761.
104. Jennings LC, Dick EC. Transmission and control of rhinovirus colds. Eur J Epidemiol 1987;3:327-335.
105. Beisal WR, Edelman R, Nauss K, Suskind RM. Single-nutrient effects of immunologic functions. JAMA 1981;245:53-58.
106. Dowd PS, Heatley RV. The influence of undernutrition on immunity. Clin Sci 1984;66:241-248.
107. Tachiban K, Sone S, Tsubura E, Kishino Y. Stimulation effect of vitamin A on tumoricidal activity of rat alveolar macrophages. Br J Cancer 1984;49:343-348.
108. Semba RD. Vitamin A, immunity, and infection. Clin Inf Dis 1994;19:489-499.
109. Tella A. Preliminary studies on nasal decongestant activity from the seed of the shea butter tree, Butyrospermum parkii. Br J Clin Pharmacol 1979;7:495-497.
110. Harris JC, Cottrell SL, Plummer S, et al. Antimicrobial properties of Allium sativa (garlic). Appl Microbial Biotechnol 2001;43:3045-3048.
111. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther 2001;18:189-193.
112. Chen HC, Chang MD, Chang TJ. Antibacterial properties of some spice plants before and after heat treatment. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1985;18:190-195. [Article in Chinese]
113. Abascal K, Yarnell E. Herbs and drug resistance. Alt Comp Ther 2002;1:284-290.
114. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 1996;43:56-62.
115. Murray BE. Problems and dilemmas of antimicrobial resistance. Pharmacotherapy 1992;12:86S-93S.